" /> Lipodystrophy, familial partial, type 2 - CISMeF





Preferred Label : Lipodystrophy, familial partial, type 2;

Symbol : FPLD2;

CISMeF acronym : FPLD2; FPL2;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Lipoatrophic diabetes; FPL2; Lipodystrophy, familial, of limbs and lower trunk; Lipodystrophy, reverse partial; Lipodystrophy, familial partial, dunnigan type;

Description : Familial partial lipodystrophy is a metabolic disorder characterized by abnormal subcutaneous adipose tissue distribution beginning in late childhood or early adult life. Affected individuals gradually lose fat from the upper and lower extremities and the gluteal and truncal regions, resulting in a muscular appearance with prominent superficial veins. In some patients, adipose tissue accumulates on the face and neck, causing a double chin, fat neck, or cushingoid appearance. Metabolic abnormalities include insulin-resistant diabetes mellitus with acanthosis nigricans and hypertriglyceridemia; hirsutism and menstrual abnormalities occur infrequently. Familial partial lipodystrophy may also be referred to as lipoatrophic diabetes mellitus, but the essential feature is loss of subcutaneous fat (review by Garg, 2004). The disorder may be misdiagnosed as Cushing disease (see 219080) (Kobberling and Dunnigan, 1986; Garg, 2004). - Genetic Heterogeneity of Familial Partial Lipodystrophy Familial partial lipodystrophy is a clinically and genetically heterogeneous disorder. Types 1 and 2 were originally described as clinical subtypes: type 1 (FPLD1; 608600), characterized by loss of subcutaneous fat confined to the limbs (Kobberling et al., 1975), and;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the lamin A/C gene (LMNA, 150330.0003);

Laboratory abnormalities : Hyperglycemia; Hyperinsulinemia; Increased serum triglycerides; Decreased HDL cholesterol;

Prefixed ID : #151660;

Details


You can consult :


Nous contacter.
10/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.